This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Levi & Korsinsky is investigating the Board of Directors of R.G. Barry Corporation (“R.G. Barry” or “the Company”) (NasdaqGS: DFZ) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Mill Road Capital
Click here to learn more about the investigation:
http://zlk.9nl.com/rgbarry-dfz, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, shareholders will receive $19.00 per share in cash for each outstanding share of R.G. Barry common stock. The transaction is currently valued at approximately $215 million. The investigation concerns whether the R.G. Barry Board of directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Mill Road is underpaying for R.G. Barry shares. In particular, at least one financial analyst set a price target for R.G. Barry stock at $21.50 per share.
If you own R.G. Barry common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at
email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. Attorney advertising. Prior results do not guarantee similar outcomes.